Ramsay Health Care Net Profit Rises 5.1%, Pivots on Strategy
By David Winning
SYDNEY--Ramsay Health Care said its annual net profit rose by 5.1% as surgical volumes improved, but the private hospital operator pointed to a shift in how it plans to navigate the aftermath of the Covid-19 pandemic.
Ramsay had been signaling that the 2024 fiscal year will mark a return to more normalized conditions following pandemic disruption when governments asked private hospitals to suspend elective surgery and free up capacity for a potential influx of Covid-19 patients.
"In light of higher development costs and disruption in the building industry combined with some of the trends that have emerged through Covid investment in the pipeline of opportunities will be modified to ensure disciplined capital allocation and focused execution of the strategy with Australia being the key priority for investment," Ramsay said on Thursday.
In Australia, Ramsay said it will put more emphasis on investing in digital and data platforms to support growth and make the business more efficient.
"Investment in the physical footprint will be focused toward treatment and diagnostics capacity in addition to investment in out of hospital activities to create a more integrated health care experience for patients," Ramsay said.
Ramsay reported a net profit of 298.1 million Australian dollars (US$191.5 million) for the 12 months through June after stripping out the impact of currency swings, up from A$274.0 million a year earlier. Earnings before interest and tax--or Ebit--increased by 13% to A$1 billion.
Ramsay, which has more than 500 hospitals and clinics in 11 countries, declared a final dividend of 25 Australian cents a share, bringing the annual payout to A$0.75 a share.
Write to David Winning at david.winning@wsj.com
(END) Dow Jones Newswires
August 23, 2023 18:52 ET (22:52 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?
-
A Cheap Dividend Aristocrat to Buy Before It Bounces Back
-
Alibaba Earnings: More Positive Outlook Despite Mixed Results
-
After Earnings and a 56% Rally In 2024, Is Arm Stock a Buy, a Sell, or Fairly Valued?
-
How Morningstar Rates Stocks
-
After Earnings, Is Disney Stock a Buy, a Sell, or Fairly Valued?
-
Home Depot Earnings: Macro Factors Pinch Demand, but Long-Term Outlook Intact